Suppr超能文献

抑郁症是否为颈椎病前路减压融合术的禁忌证?

Is depression the contraindication of anterior cervical decompression and fusion for cervical spondylosis?

机构信息

Department of Psychiatry, The First Branch, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Department of Psychiatry, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

出版信息

Front Endocrinol (Lausanne). 2022 Sep 30;13:1031616. doi: 10.3389/fendo.2022.1031616. eCollection 2022.

Abstract

OBJECTIVE

To evaluate whether depression is the contraindication of anterior cervical decompression and fusion (ACDF) for cervical spondylosis.

MATERIAL AND METHODS

Patients with single-segment cervical spondylosis who underwent ACDF from January 2015 to December 2018 in our department were retrospectively included in this study and divided into two groups. Patients who were diagnosed of depression and prescribed with antidepressant drugs for at least 6 months before surgery were included in the intervention group. Patients without depression were included in the control group. The Beck Depression Inventory (BDI) score was used to evaluate the severity of depression. Visual Analogue Scale (VAS) score, Japanese Orthopeadic Association (JOA) score, Neck Disability Index (NDI), and the 36-Item Short-Form Health Survey (SF-36) were recorded as indexes to assess the pain, cervical spine function, degree of cervical spine injury, and life quality, respectively. The operative time, operative blood loss, hospital stay and complications were also recorded and compared.

RESULTS

A total of 117 patients were included in this study, involving 32 patients in the intervention group and 85 patients in the control group. No significant differences were found in operative time, operative blood loss, hospital stay and complications between the two groups (P>0.05). The BDI score, VAS score, JOA score, NDI, SF-36 physical component score (SF-36 PCS) and SF-36 mental component score (SF-36 MCS) were all significantly improved at last follow-up in both the two groups. The intervention group showed higher BDI score and SF-36 MCS than the control group at both preoperative and the last follow-up (P<0.05), and the improvements of BDI score and SF-36 MCS were also higher in the intervention group (P<0.05). Although the intervention group showed higher VAS score, NDI, SF-36 PCS and lower JOA score at preoperative and last follow-up, respectively (P<0.05), there were no significant differences in the improvements of these indexes between the two group (P>0.05).

CONCLUSIONS

Depression is not the contraindication of ACDF for cervical spondylosis. Depression patients who received preoperative antidepressants can achieve similar improvement of clinical symptoms from ACDF with non-depression patients.

摘要

目的

评估抑郁症是否为颈椎病前路减压融合术(ACDF)的禁忌证。

材料与方法

回顾性纳入我科 2015 年 1 月至 2018 年 12 月接受 ACDF 的单节段颈椎病患者,将其分为两组。术前诊断为抑郁症并服用抗抑郁药至少 6 个月的患者纳入干预组,无抑郁症的患者纳入对照组。采用贝克抑郁量表(BDI)评分评估抑郁严重程度,记录视觉模拟量表(VAS)评分、日本骨科协会(JOA)评分、颈部残疾指数(NDI)和 36 项简明健康状况调查问卷(SF-36)评分,以评估疼痛、颈椎功能、颈椎损伤程度和生活质量。记录并比较手术时间、术中出血量、住院时间和并发症。

结果

本研究共纳入 117 例患者,其中干预组 32 例,对照组 85 例。两组患者的手术时间、术中出血量、住院时间和并发症无统计学差异(P>0.05)。两组患者在末次随访时 BDI 评分、VAS 评分、JOA 评分、NDI、SF-36 生理功能评分(SF-36 PCS)和 SF-36 心理功能评分(SF-36 MCS)均明显改善,干预组术前和末次随访时的 BDI 评分和 SF-36 MCS 评分均高于对照组(P<0.05),且干预组 BDI 评分和 SF-36 MCS 评分改善程度也高于对照组(P<0.05)。干预组术前和末次随访时 VAS 评分、NDI、SF-36 PCS 较高,JOA 评分较低(P<0.05),但两组间各指标改善程度无统计学差异(P>0.05)。

结论

抑郁症不是颈椎病前路减压融合术的禁忌证。术前接受抗抑郁治疗的抑郁症患者与非抑郁症患者行 ACDF 后,其临床症状改善程度相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e919/9561543/01ceab2a1742/fendo-13-1031616-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验